End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16,900 KRW | -0.65% | +2.36% | -13.73% |
01-08 | CHA Biotech to Partner with Subsidiary to Advance NK Cell Therapy | MT |
2023 | CHA Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Sales 2022 | 845B 614M 49.17B | Sales 2023 | 954B 694M 55.53B | Capitalization | 1,103B 802M 64.22B |
---|---|---|---|---|---|
Net income 2022 | -47.54B -34.56M -2.77B | Net income 2023 | -8.43B -6.13M -491M | EV / Sales 2022 | 1.13 x |
Net Debt 2022 | 225B 164M 13.1B | Net Debt 2023 | 228B 166M 13.26B | EV / Sales 2023 | 1.4 x |
P/E ratio 2022 |
-15.4
x | P/E ratio 2023 |
-112
x | Employees | 312 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 69.17% |
1 day | -0.65% | ||
1 week | +2.36% | ||
Current month | -13.16% | ||
1 month | -13.51% | ||
3 months | -4.03% | ||
6 months | +6.49% | ||
Current year | -13.73% |
Managers | Title | Age | Since |
---|---|---|---|
Sang-Hoon Oh
CEO | Chief Executive Officer | 60 | 28/02/19 |
Dong-Joon Lee
DFI | Director of Finance/CFO | 53 | 31/03/19 |
Jong-Guk Song
PSD | President | 63 | 31/12/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sang-kyu Lee
BRD | Director/Board Member | 72 | - |
Jong-Guk Song
PSD | President | 63 | 31/12/05 |
Joong-Ho Kim
BRD | Director/Board Member | 80 | 30/04/08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 2 M€ | -.--% | ||
0.01% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | +1.11% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 16,900 | -0.65% | 154,683 |
25/04/24 | 17,010 | -1.05% | 109,477 |
24/04/24 | 17,190 | +0.06% | 123,333 |
23/04/24 | 17,180 | +0.82% | 155,613 |
22/04/24 | 17,040 | +3.21% | 198,414 |
End-of-day quote Korea S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-13.73% | 691M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- A085660 Stock